Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study
Advanced glycation end-products (AGEs) are a heterogeneous group of compounds formed by the non-enzymatic reaction between amino-acids and reducing sugars, or dicarbonyls as intermediate compounds. Experimental studies suggest that AGEs may promote colorectal cancer, but prospective epidemiologic st...
Main Authors: | Aglago, EK, Schalkwijk, CG, Freisling, H, Fedirko, V, Hughes, DJ, Jiao, L, Dahm, CC, Olsen, A, Tjønneland, A, Katzke, V, Johnson, T, Schulze, MB, Aleksandrova, K, Masala, G, Sieri, S, Simeon, V, Tumino, R, Macciotta, A, Bueno-de-Mesquita, B, Skeie, G, Gram, IT, Sandanger, T, Jakszyn, P, Sánchez, M-J, Amiano, P, Colorado-Yohar, SM, Gurrea, AB, Mayén, A-L, Weiderpass, E, Gunter, MJ, Heath, AK, Jenab, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2021
|
Similar Items
-
Soluble receptor for advanced glycation end-products (sRAGE) and colorectal cancer risk: a case–control study nested within a European prospective cohort
by: Aglago, EK, et al.
Published: (2020) -
Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
by: Aglago, EK, et al.
Published: (2021) -
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study
by: Reynalda Córdova, et al.
Published: (2022-10-01) -
Red blood cell fatty acids and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Linseisen, J, et al.
Published: (2021) -
Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
by: Elom K. Aglago, et al.
Published: (2021-09-01)